Detalhe da pesquisa
1.
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
Cell
; 185(14): 2591-2608.e30, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803246
2.
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 389(24): 2256-2266, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870955
3.
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 385(13): 1196-1206, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551229
4.
Cutaneous type IV hypersensitivity reaction following tebentafusp treatment for uveal melanoma.
Dermatol Online J
; 29(6)2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478664
5.
Clinical and genomic correlates of imatinib response in melanomas with KIT alterations.
Br J Cancer
; 127(9): 1726-1732, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999272
6.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
J Transl Med
; 20(1): 391, 2022 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058945
7.
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 990-1000, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767205
8.
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
Am J Transplant
; 21(2): 475-483, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976703
9.
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.
Am J Transplant
; 21(2): 460-474, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969590
10.
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
Invest New Drugs
; 39(5): 1284-1297, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852104
11.
LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.
Invest New Drugs
; 39(4): 1057-1071, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624233
12.
Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial.
Eur Radiol
; 31(4): 1853-1862, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32995974
13.
Analysis of malignant melanoma risk and outcomes in solid organ transplant recipients: Assessment of transplant candidacy and the potential role of checkpoint inhibitors.
Clin Transplant
; 35(5): e14264, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709489
14.
Cellular therapy for the treatment of solid tumors.
Transfus Apher Sci
; 60(1): 103056, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33478888
15.
A Case Report of Papillary Digital Adenocarcinoma With BRAFV600E Mutation and Quantified Mutational Burden.
Am J Dermatopathol
; 43(1): 57-59, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32568833
16.
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
J Transl Med
; 18(1): 346, 2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894202
17.
Novel Approaches to the Systemic Management of Uveal Melanoma.
Curr Oncol Rep
; 22(10): 104, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32725406
18.
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
Oncologist
; 24(6): 857-863, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126857
19.
Novel Targets for the Treatment of Melanoma.
Curr Oncol Rep
; 21(11): 97, 2019 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696329
20.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
Invest New Drugs
; 36(1): 103-113, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29127533